TerrAscend (TSNDF) Gross Margin (2021 - 2026)

TerrAscend's (TSNDF) quarterly Gross Margin came in at 52.8% in Q1 2026, down 114.0% year-on-year from 377.11% in Q1 2025, and up 1.28% on a QoQ basis from 52.13% in Q4 2025.

TerrAscend (TSNDF) Gross Margin (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Gross Margin data on file, last reported at 52.8% in Q1 2026.

  • On a quarterly basis, Gross Margin fell 114.0% year-over-year to 52.8% in Q1 2026; TTM through Mar 2026 was 52.04%, a 21.0% increase from a year earlier, with the FY2025 full-year figure at 52.32%, up 164.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 52.8%, up from 52.13% in the prior quarter.
  • Over the last five years, Gross Margin for TSNDF reached as high as 101.72% in Q4 2023 and fell as low as 31.85% in Q1 2022.
  • Historically, Gross Margin has averaged 51.73% across 5 years, with a median of 50.97% in 2024.
  • Across the five-year window, Gross Margin jumped 5641 bps in 2023 and plunged 4885 bps in 2024, its largest moves.
  • Year by year, Gross Margin stood at 45.3% in 2022, then jumped by 125 bps to 101.72% in 2023, then plunged by 48 bps to 52.87% in 2024, then fell by 1 bps to 52.13% in 2025, then climbed by 1 bps to 52.8% in 2026.
  • Per Business Quant data, the three most recent Gross Margin figures were 52.8% in Q1 2026, 52.13% in Q4 2025, and 52.11% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn 52.80%

Historic Data

Download Data
DateValue
Mar 31, 2026 52.80%
Dec 31, 2025 52.13%
Sep 30, 2025 52.11%
Jun 30, 2025 51.13%
Mar 31, 2025 53.93%
Dec 31, 2024 52.87%
Sep 30, 2024 50.97%
Jun 30, 2024 49.64%
Mar 31, 2024 48.03%
Dec 31, 2023 101.72%
Sep 30, 2023 53.57%
Jun 30, 2023 50.23%
Mar 31, 2023 48.85%
Dec 31, 2022 45.30%
Sep 30, 2022 47.00%
Jun 30, 2022 37.29%
Mar 31, 2022 31.85%
Dec 31, 2021 84.24%
Sep 30, 2021 43.75%
Jun 30, 2021 56.21%